Dr Reddy's plans EU launch for biosimilar cancer treatment Zenopa Dr Reddy's Laboratories is planning to launch a biosimilar version of Roche's non-Hodgkin's lymphoma treatment rituximab in Europe. The company is in talks with European regulators about the potential launch of Reditux, which is the world's first ... |
